Prawo i regulacje · 06/08/2010

DEA Corrects Scheduling of 2C-T-7 and N-Benzylpiperazine

The Drug Enforcement Administration (DEA) is issuing a correction to a 2004 rule that placed N-Benzylpiperazine (BZP) and 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) into Schedule I of the Controlled Substances Act, correcting an error regarding the potency of BZP relative to amphetamine.